THE LATEST FROM MiRus

MoRe® News

Press Releases

December 2, 2021

MiRus® Announces Plans for Site of New Headquarters

MiRus announces plans for site of new headquarters with the purchase of the Franklin Gateway 6.72 acre property from the City of Marietta. The new headquarters will be a three-story facility comprising over 70,000 square feet. https://www.mariettaga.gov/CivicAlerts.aspx?AID=3474
Read More →
August 31, 2021

MiRus® Receives FDA 510(K) Clearance For
The Lowest Profile and Best-in-class Expandable Lumbar Interbody

ATLANTA- August 31, 2021 – MiRus LLC, the leading innovator in rhenium-based superalloy medical implants announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its IO™ Expandable Lumbar Interbody. The IO™ Expandable Lumbar Interbody can be utilized in both PLIF and TLIF procedures.  It features the lowest insertion profile …

MiRus® Receives FDA 510(K) Clearance For
The Lowest Profile and Best-in-class Expandable Lumbar Interbody Read More »

Read More →
July 27, 2021

MiRus® Raises $65 Million For Expansion of Rhenium-based Medical Devices

ATLANTA- July 27, 2021 – MiRus LLC, a commercial stage life sciences company, has completed a highly oversubscribed funding round for growth of its spine and extremity portfolios and development of structural heart disease solutions using its proprietary Rhenium-based alloys (MoRe®).  The round was led by Mammoth Scientific and multi-generational family offices who have supported …

MiRus® Raises $65 Million For Expansion of Rhenium-based Medical Devices Read More »

Read More →
February 23, 2021

MiRus® Launches MoRe® Promise- a Lifetime Limited Warranty for its Molybdenum-Rhenium Superalloy Rod.

MiRus announced today that they will offer a LIFETIME LIMITED WARRANTY on its Molybdenum-Rhenium ( MoRe®) superalloy rod technology. The warranty will cover full replacement of the MoRe® Rod and corresponding MiRus hardware used in spinal fusion cases should the MoRe® Rod fracture. The warranty will cover all thoracolumbar MoRe® rods implanted as part of the EUROPA™ Pedicle Screw System supplied by MiRus in the United States effective March 1, 2021.
Read More →
June 11, 2020

MiRus® Announces First Clinical Use of the MiRus® 3DR™ Printed Lumbar Interbody Fusion System.

MiRus is pleased to announce that it received FDA 510(k) clearance for its 3DR™ (Randomized) Printed Lumbar Interbody Fusion System which consists of the CALLISTO 3DR™ PLIF, HYPERION 3DR™ TLIF, CALYPSO 3DR™ LLIF and the ANTARES 3DR™ ALIF.
Read More →
August 30, 2019

First Spine Surgeries using the MoRe® Superalloy.

MiRus announces successful spine surgeries at several centers across the country using the MoRe® superalloy. MiRus had received FDA 510(k) clearance for the MoRe® based Europa™ Pedicle Screw System earlier this year.
Read More →
July 26, 2019

MiRus® Receives FDA Clearance for Lowest Profile Anterior Cervical Plate System.

MiRus is pleased to announce recent FDA 510(k) clearance of the CYGNUS™ Anterior Cervical Plate System, the narrowest and thinnest cervical plate on the market.
Read More →
July 22, 2019

First System for Dynamic Intra-operative Measurement of Segmental and Global Spine Alignment Receives FDA Clearance.

MiRus is pleased to announce FDA 510(k) clearance of the GALILEO™ Spine Alignment Monitoring System, a non-optical, wireless, real-time measurement system for segmental and global sagittal spine alignment.
Read More →
June 24, 2019

MiRus Aquires 50,000 SQFT Manufacturing Facility.

Following the 510(k) clearance by FDA in March 2019 of MoRe®, a proprietary molybdenum rhenium superalloy for medical implants, MiRus is excited to announce a major expansion of its manufacturing capacity with the addition of a fully operational 50,000 sqft orthopaedic and spine manufacturing plant in Marietta, GA.
Read More →
March 27, 2019

MiRus Receives FDA 510(k) Approval for First Medical Implant with New Superalloy.

MiRus has received FDA 510(k) approval for the MoRe® based Europa™ Pedicle Screw System making it the first FDA approved medical device with this new class of implant material.
Read More →

Dr. Yadav - Inventing A Healthier Future

Play Video

The Latest from MiRus

CardioMEMS HF Monitoring System Decreases Mortality by 25% at 2 Years in HFrEF Patients

March 23, 2023

MiRus® Announces FDA 510(k) Clearance for Molybdenum-Rhenium Low Profile Anterior Cervical Plate System

August 16, 2022

MiRus® Receives 2022 Pacesetter Award

May 3, 2022

MiRus® Receives FDA 510(K) Clearance For
The Lowest Profile and Best-in-class Expandable Lumbar Interbody

August 31, 2021